Skip to content
XPR
content.
Press releases
Video
Podcasts
Op-eds
Lists
Guest posts
Author:
Lexaria Bioscience Corp.
Lexaria Enters a Material Transfer Agreement With PegBio
August 13, 2026
Lexaria Announces Effective Date for Reverse Stock Split
July 30, 2026
Lexaria Updates Business Development
July 6, 2026
Lexaria’s Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
June 25, 2026
Lexaria’s Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule
June 23, 2026
GLP-1 ‘Arms Race’ Intensifies as the Addressable Markets Continue to Expand
June 17, 2026
Lexaria’s Animal Study Examining Next-Generation GLP-1 drugs is Underway
June 9, 2026
Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program
June 3, 2026